Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

[Interventional treatment of tracheopleural and bronchopleural fistulas].

Klotz LV, Eberhardt R, Herth FJF, Winter H.

Chirurg. 2019 Jun 3. doi: 10.1007/s00104-019-0977-2. [Epub ahead of print] Review. German.

PMID:
31161248
2.

Club cells form lung adenocarcinomas and maintain the alveoli of adult mice.

Spella M, Lilis I, Pepe MA, Chen Y, Armaka M, Lamort AS, Zazara DE, Roumelioti F, Vreka M, Kanellakis NI, Wagner DE, Giannou AD, Armenis V, Arendt KAM, Klotz LV, Toumpanakis D, Karavana V, Zakynthinos SG, Giopanou I, Marazioti A, Aidinis V, Sotillo R, Stathopoulos GT.

Elife. 2019 May 29;8. pii: e45571. doi: 10.7554/eLife.45571. [Epub ahead of print]

3.

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial.

Eichhorn F, Klotz LV, Bischoff H, Thomas M, Lasitschka F, Winter H, Hoffmann H, Eichhorn ME.

BMC Cancer. 2019 May 2;19(1):413. doi: 10.1186/s12885-019-5624-2.

4.

Comprehensive clinical profiling of the Gauting locoregional lung adenocarcinoma donors.

Klotz LV, Courty Y, Lindner M, Petit-Courty A, Stowasser A, Koch I, Eichhorn ME, Lilis I, Morresi-Hauf A, Arendt KAM, Pepe M, Giopanou I, Ntaliarda G, Behrend SJ, Oplopoiou M, Gissot V, Guyetant S, Marchand-Adam S, Behr J, Kaiser JC, Hatz RA, Lamort AS, Stathopoulos GT.

Cancer Med. 2019 Apr;8(4):1486-1499. doi: 10.1002/cam4.2031. Epub 2019 Feb 25.

5.

Persistence of de novo donor specific HLA-Antibodies after lung transplantation: a potential marker of decreased patient survival.

Schmitzer M, Winter H, Kneidinger N, Meimarakis G, Dick A, Schramm R, Klotz LV, Preissler G, Strobl N, von Dossow V, Schneider C, Weig T, Hatz R, Kauke T.

HLA. 2018 Jun 10. doi: 10.1111/tan.13306. [Epub ahead of print]

PMID:
29888557
6.

Intraoperative Anesthetic Management of Lung Transplantation: Center-Specific Practices and Geographic and Centers Size Differences.

Tomasi R, Betz D, Schlager S, Kammerer T, Hoechter DJ, Weig T, Slinger P, Klotz LV, Zwißler B, Marczin N, von Dossow V.

J Cardiothorac Vasc Anesth. 2018 Feb;32(1):62-69. doi: 10.1053/j.jvca.2017.05.025. Epub 2017 May 17.

PMID:
29174123
7.

Vascular Leiomyoma of the Pulmonary Artery.

Klotz LV, Morresi-Hauf A, Hatz RA, Lindner M.

Ann Thorac Surg. 2016 Jan;101(1):342-4. doi: 10.1016/j.athoracsur.2015.02.113.

PMID:
26694272
8.

Endobronchial closure of bronchopleural fistula using Amplatzer device.

Klotz LV, Gesierich W, Schott-Hildebrand S, Hatz RA, Lindner M.

J Thorac Dis. 2015 Aug;7(8):1478-82. doi: 10.3978/j.issn.2072-1439.2015.08.25.

9.

[Pulmonary Tuberculosis--Is Surgery still Necessary?].

Klotz LV, Lindner M, Hatz RA.

Zentralbl Chir. 2015 Oct;140 Suppl 1:S36-42. doi: 10.1055/s-0035-1546249. Epub 2015 Sep 9. Review. German.

PMID:
26351762
10.

Contrast-enhanced Ultrasound Imaging of Antiangiogenic Tumor Therapy.

Klotz LV, Clevert DA, Scheckinger S, Strieth S, Eichhorn ME.

Anticancer Res. 2015 May;35(5):2571-6.

PMID:
25964532
11.

Monitoring parotid gland tumors with a new perfusion software for contrast-enhanced ultrasound.

Klotz LV, Ingrisch M, Eichhorn ME, Niemoeller O, Siedek V, Gürkov R, Clevert DA.

Clin Hemorheol Microcirc. 2014;58(1):261-9. doi: 10.3233/CH-141895.

PMID:
25339101
12.

Perfusion characteristics of parotid gland tumors evaluated by contrast-enhanced ultrasound.

Klotz LV, Gürkov R, Eichhorn ME, Siedek V, Krause E, Jauch KW, Reiser MF, Clevert DA.

Eur J Radiol. 2013 Dec;82(12):2227-32. doi: 10.1016/j.ejrad.2013.08.033. Epub 2013 Aug 30.

PMID:
24029161
13.

[Consequences of pneumonectomy in the early and late phases].

Hatz RA, Klotz LV.

Chirurg. 2013 Jun;84(6):497-501. doi: 10.1007/s00104-012-2434-3. Review. German.

PMID:
23681366
14.

[Swelling of the neck following tonsillectomy. Lateral cervical fistula].

Klotz LV, Reichel O.

HNO. 2014 Jan;62(1):41-3. doi: 10.1007/s00106-012-2656-1. German. Erratum in: HNO. 2014 Aug;62(8):563.

PMID:
23515593
15.

Validation of contrast-enhanced ultrasound-derived intensity-time gradients in submandibular gland sialolithotomy patients.

Siedek V, Rytvina M, Klotz LV, Berghaus A, Clevert DA, Strieth S.

Eur Arch Otorhinolaryngol. 2013 May;270(6):1941-6. doi: 10.1007/s00405-012-2278-y. Epub 2012 Dec 9.

PMID:
23223886
16.

Contrast-enhanced ultrasound for monitoring effects of extracorporeal shock wave sialolithotripsy in sialolithiasis.

Siedek V, Clevert DA, Rytvina M, Ihrler S, Klotz LV, Berghaus A, Strieth S.

Laryngoscope. 2012 Jun;122(6):1301-5. doi: 10.1002/lary.23281. Epub 2012 Apr 20.

PMID:
22522958
17.

Targeting the vasculature of visceral tumors: novel insights and treatment perspectives.

Klotz LV, Eichhorn ME, Schwarz B, Seeliger H, Angele MK, Jauch KW, Bruns CJ.

Langenbecks Arch Surg. 2012 Apr;397(4):569-78. doi: 10.1007/s00423-012-0946-4. Epub 2012 Mar 14. Review.

PMID:
22415155
18.

Vascular targeting tumor therapy: non-invasive contrast enhanced ultrasound for quantitative assessment of tumor microcirculation.

Eichhorn ME, Klotz LV, Luedemann S, Strieth S, Kleespies A, Preissler G, Lindner M, Jauch KW, Reiser MF, Clevert DA.

Cancer Biol Ther. 2010 May 15;9(10):794-802.

PMID:
20234173

Supplemental Content

Loading ...
Support Center